Evolutec raises L5.7M in an IPO

Inflammatory and autoimmune company Evolutec (Oxford, U.K.) raised L5.7 million ($10.6 million) through the sale of 4.6 million shares at 125p in an IPO. The company expects to list on London's AIM ma...